Irritable bowel syndrome, type unspecified

ONTOLOGY PAGE

DD91.0Z

SANKEY PLOT

Irritable bowel syndrome, type unspecified
Diseases of the digestive system
Dicyclomine
M1 receptor
Endo-atropine
Trimebutine
M3 receptor
Butylscopolamine
Prucalopride
5-HT4 receptor
(+)-sulpiride
Sulpiride,(-)
Mosapride
M2 receptor
Cidoxepin
H2 receptor
Doxepin
H1 receptor
Octreotide
SST1 receptor
SST2 receptor
SST4 receptor
SST3 receptor
SST5 receptor
M4 receptor
μ receptor
Eluxadoline
Itopride
D2 receptor
Vibegron
β3-adrenoceptor
δ receptor
κ receptor
Alverine
5-HT1A receptor
Nortriptyline
5-HT2A receptor
δ9-tetrahydrocannabinol
CB1 receptor
CB2 receptor
Clf065
GLP-2 receptor
Glepaglutide

PROTEIN TARGETS

acm1_human,

acm3_human,

5ht4r_human,

acm2_human,

hrh2_human,

hrh1_human,

ssr1_human,

ssr2_human,

ssr4_human,

ssr3_human,

ssr5_human,

acm4_human,

oprm_human,

drd2_human,

adrb3_human,

oprd_human,

oprk_human,

5ht1a_human,

5ht2a_human,

cnr1_human,

cnr2_human,

glp2r_human

DRUGS

Dicyclomine,

Endo-atropine,

Trimebutine,

Butylscopolamine,

Prucalopride,

(+)-sulpiride,

Sulpiride,(-),

Mosapride,

Cidoxepin,

Doxepin,

Doxepin,

Octreotide,

Eluxadoline,

Itopride,

Vibegron,

Alverine,

Nortriptyline,

δ9-tetrahydrocannabinol,

Clf065,

Glepaglutide